CN1356903A - 含哌嗪环化合物的新型合成和结晶方法 - Google Patents

含哌嗪环化合物的新型合成和结晶方法 Download PDF

Info

Publication number
CN1356903A
CN1356903A CN00807574A CN00807574A CN1356903A CN 1356903 A CN1356903 A CN 1356903A CN 00807574 A CN00807574 A CN 00807574A CN 00807574 A CN00807574 A CN 00807574A CN 1356903 A CN1356903 A CN 1356903A
Authority
CN
China
Prior art keywords
mirtazapine
phenyl
methyl
piperazine
solvent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN00807574A
Other languages
English (en)
Chinese (zh)
Inventor
克劳德·辛格
安尼塔·利伯曼
尼娜·芬克尔斯坦
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teva Pharmaceutical Industries Ltd
Original Assignee
Teva Pharmaceutical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharmaceutical Industries Ltd filed Critical Teva Pharmaceutical Industries Ltd
Publication of CN1356903A publication Critical patent/CN1356903A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
CN00807574A 1999-04-19 2000-04-18 含哌嗪环化合物的新型合成和结晶方法 Pending CN1356903A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13004799P 1999-04-19 1999-04-19
US60/130,047 1999-04-19

Related Child Applications (3)

Application Number Title Priority Date Filing Date
CNA2005100042895A Division CN1680374A (zh) 1999-04-19 2000-04-18 含哌嗪环化合物的新型合成和结晶方法
CNA2005100042880A Division CN1679586A (zh) 1999-04-19 2000-04-18 含哌嗪环化合物的新型合成和结晶方法
CNA2005100042908A Division CN1680365A (zh) 1999-04-19 2000-04-18 含哌嗪环化合物的新型合成和结晶方法

Publications (1)

Publication Number Publication Date
CN1356903A true CN1356903A (zh) 2002-07-03

Family

ID=22442814

Family Applications (4)

Application Number Title Priority Date Filing Date
CN00807574A Pending CN1356903A (zh) 1999-04-19 2000-04-18 含哌嗪环化合物的新型合成和结晶方法
CNA2005100042895A Pending CN1680374A (zh) 1999-04-19 2000-04-18 含哌嗪环化合物的新型合成和结晶方法
CNA2005100042880A Pending CN1679586A (zh) 1999-04-19 2000-04-18 含哌嗪环化合物的新型合成和结晶方法
CNA2005100042908A Pending CN1680365A (zh) 1999-04-19 2000-04-18 含哌嗪环化合物的新型合成和结晶方法

Family Applications After (3)

Application Number Title Priority Date Filing Date
CNA2005100042895A Pending CN1680374A (zh) 1999-04-19 2000-04-18 含哌嗪环化合物的新型合成和结晶方法
CNA2005100042880A Pending CN1679586A (zh) 1999-04-19 2000-04-18 含哌嗪环化合物的新型合成和结晶方法
CNA2005100042908A Pending CN1680365A (zh) 1999-04-19 2000-04-18 含哌嗪环化合物的新型合成和结晶方法

Country Status (16)

Country Link
JP (1) JP2004500324A (enExample)
KR (1) KR20020019902A (enExample)
CN (4) CN1356903A (enExample)
CA (1) CA2368815A1 (enExample)
CZ (1) CZ20013658A3 (enExample)
HK (1) HK1044116A1 (enExample)
HR (1) HRP20010747A2 (enExample)
HU (1) HUP0200839A3 (enExample)
IL (1) IL146023A0 (enExample)
PL (1) PL366289A1 (enExample)
RU (1) RU2001128229A (enExample)
SK (1) SK14672001A3 (enExample)
TR (1) TR200103028T2 (enExample)
WO (1) WO2000062782A1 (enExample)
YU (1) YU74101A (enExample)
ZA (1) ZA200108220B (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101541798B (zh) * 2007-03-22 2011-09-14 住友化学株式会社 米氮平的制造方法
CN108191873A (zh) * 2018-01-08 2018-06-22 山东省食品药品检验研究院 一种盐酸米安色林的纯化方法

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6019900A (en) * 1999-11-24 2001-06-04 Sumika Fine Chemicals Co., Ltd. Anhydrous mirtazapine crystals and process for producing the same
WO2001042239A1 (en) * 1999-12-13 2001-06-14 Sumika Fine Chemicals Co., Ltd. Process for the preparation of a pyridinemethanol compound
US6660730B2 (en) * 2000-11-27 2003-12-09 Sumika Fine Chemicals Co., Ltd. Anhydrous mirtazapine and process for preparing the same
UA83666C2 (ru) * 2003-07-10 2008-08-11 Н.В. Органон Способ получения энантиомерно чистого миртазапина
ES2246161B1 (es) * 2004-07-22 2007-04-01 Medichem, S.A. Proceso mejorado para la fabricacion de mirtazapina.
JP4848704B2 (ja) * 2004-08-24 2011-12-28 住友化学株式会社 ２−（４−メチル−２−フェニルピペラジン−１−イル）−３−シアノピリジンの製造方法
US7994314B2 (en) 2007-04-11 2011-08-09 N.V. Organon Method for the preparation of an enantiomerically pure benzazepine
CA2684021A1 (en) 2007-04-11 2008-10-23 N.V. Organon A method for the preparation of an enantiomer of a tetracyclic benzazepine
KR101485418B1 (ko) 2013-05-29 2015-01-26 주식회사 메디켐코리아 고순도 미르타자핀의 제조방법
JP6571497B2 (ja) * 2015-11-13 2019-09-04 株式会社トクヤマ ミルタザピンの製造方法
JP2017088564A (ja) * 2015-11-13 2017-05-25 株式会社トクヤマ ミルタザピンの製造方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL189199C (nl) * 1975-04-05 1993-02-01 Akzo Nv Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten.

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101541798B (zh) * 2007-03-22 2011-09-14 住友化学株式会社 米氮平的制造方法
CN108191873A (zh) * 2018-01-08 2018-06-22 山东省食品药品检验研究院 一种盐酸米安色林的纯化方法

Also Published As

Publication number Publication date
IL146023A0 (en) 2002-07-25
CN1679586A (zh) 2005-10-12
YU74101A (sh) 2004-09-03
HRP20010747A2 (en) 2002-12-31
WO2000062782A1 (en) 2000-10-26
RU2001128229A (ru) 2003-07-10
CN1680365A (zh) 2005-10-12
HUP0200839A3 (en) 2003-05-28
KR20020019902A (ko) 2002-03-13
HK1044116A1 (zh) 2002-10-11
CZ20013658A3 (cs) 2002-08-14
HUP0200839A2 (en) 2002-08-28
TR200103028T2 (tr) 2002-01-21
JP2004500324A (ja) 2004-01-08
CA2368815A1 (en) 2000-10-26
PL366289A1 (en) 2005-01-24
CN1680374A (zh) 2005-10-12
ZA200108220B (en) 2006-02-26
SK14672001A3 (sk) 2002-11-06

Similar Documents

Publication Publication Date Title
KR102773538B1 (ko) 타피나로프의 제조 방법
CN1356903A (zh) 含哌嗪环化合物的新型合成和结晶方法
CN1108029A (zh) 克拉维酸的二胺盐
US6545149B2 (en) Synthesis and crystallization of piperazine ring-containing compounds
TWI851781B (zh) 製備一氧化氮供體型前列腺素類似物之方法
US20060173178A1 (en) Process for preparing dibenzothiazepine derivatives
US20030069417A1 (en) Novel synthesis and crystallization of piperazine ring-containing compounds
JPWO2001004106A1 (ja) ジベンゾチアゼピン誘導体の製造法
US20040176591A1 (en) Novel synthesis and crystallization of peperazine ring-containing compounds
EP0569387A1 (en) Racemate resolution of trans-2- (2-pyrimidinyl) -7- (hydroxymethyl) octahydro-2H-pyrido [1,2-a] pyrazine.
JP2594780B2 (ja) セファロスポリン誘導体の新規製造方法
CN112521298B (zh) 一种利多卡因的合成方法
EP0013726B1 (en) Indanyloxamic derivatives, their preparation and pharmaceutical compositions containing them
CN113912545B (zh) 一种萘甲唑啉无机酸盐的合成与精制方法
JP4699582B2 (ja) １ｈ−４（５）−アミノイミダゾール−５（４）−カルボキサミドの製造方法
US6008413A (en) Process for recrystallizing 1,3-bis(aminophenoxy benzene)
WO2008035189A1 (en) A method for the purification of lansoprazole
AU2005201117A1 (en) Novel synthesis and crystallization of piperazine ring-containing compounds
JPS6343382B2 (enExample)
KR100958678B1 (ko) 시스-디메크로틴산 및 이의 염의 제조방법
KR100297802B1 (ko) 2-(3-트리플루오로메틸)아닐리노니코틴산2-(n-몰포린)에틸의제조방법.
JPH0651697B2 (ja) ２−（１０，１１−ジヒドロ−１０−オキソジベンゾ〔ｂ，ｆ〕チエピン−２−イル）プロピオン酸の精製法
JPS6317869A (ja) ２−低級アルキル−４−アミノ−５−ホルミルピリミジンの製造法
JPS62116548A (ja) アミノケトン誘導体
JPH072741B2 (ja) （−）−１６−ブロモビンカジホルミンおよびその製造方法

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication